Physician profile
Farid Gharagozloo
NPI 1871533653
$60,592.05
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $18K · 2021: $12K · 2022: $3,279 · 2023: $13K · 2024: $15K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $24K · Travel and Lodging: $3,000 · Food and Beverage: $693 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,551.08 |
| Travel and Lodging | $3,000.21 |
| Food and Beverage | $692.83 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $33,428.09 | 2019-2024 | Arthrex |
| Medicaroid, INC. | $23,555.02 | 2021-2024 | |
| Intuitive Surgical, INC. | $3,279.27 | 2022 | |
| Bard Access Systems, INC. | $140.48 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $131.44 | 2023 | Imfinzi |
| Csl Behring | $44.28 | 2023-2024 | Kcentra |
| Medtronic, INC. | $13.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farid Gharagozloo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.